Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice
- PMID: 18644402
- PMCID: PMC2583134
- DOI: 10.1016/j.taap.2008.06.013
Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice
Abstract
Polychlorinated biphenyls (PCBs) are persistent and ubiquitous environmental chemicals that bioaccumulate and have hepatic tumor promoting activity in rodents. The present study examined the effect of deleting the p50 subunit of NF-kappaB on the hepatic tumor promoting activity of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) in mice. Both wild-type and p50-/- male mice were injected i.p. with diethylnitrosamine (DEN, 90 mg/kg) and then subsequently injected biweekly with 20 i.p. injections of PCB-153 (300 micromol/kg/injection). p50 deletion decreased the tumor incidence in both PCB- and vehicle-treated mice, whereas PCB-153 slightly (P=0.09) increased the tumor incidence in wild-type and p50-/- mice. PCB-153 increased the total tumor volume in both wild-type and p50-/- mice, but the total tumor volume was not affected by p50 deletion in either PCB- or vehicle-treated mice. The volume of tumors that were positive for glutamine synthetase (GS), which is indicative of mutations in the beta-catenin gene, was increased in both wild-type and p50-/- mice administered PCB-153 compared to vehicle controls, and inhibited in p50-/- mice compared to wild-type mice (in both PCB- and vehicle-treated mice). The volume of tumors that were negative for GS was increased in p50-/- mice compared to wild-type mice but was not affected by PCB-153. PCB-153 increased cell proliferation in normal hepatocytes in wild-type but not p50-/- mice; this increase was inhibited in p50-/- mice. In hepatic tumors, the rate of cell proliferation was much higher than in normal hepatocytes, but was not affected by PCB treatment or p50 deletion. The rate of apoptosis, as measured by the TUNEL assay, was not affected by PCB-153 or p50 deletion in normal hepatocytes. In hepatic tumors, the rate of apoptosis was lower than in normal hepatocytes; PCB-153 slightly (P=0.10) increased apoptosis in p50-/- but not wild-type mice; p50 deletion had no effect. Taken together, these data indicate that the absence of the NF-kappaB p50 subunit inhibits the promoting activity of PCB-153 and alters the proliferative and apoptotic changes in mouse liver in the response to PCBs.
Conflict of interest statement
There are no conflicts of interest.
Figures







Similar articles
-
Effect of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-kappaB.Toxicol Sci. 2004 Sep;81(1):35-42. doi: 10.1093/toxsci/kfh193. Epub 2004 Jun 16. Toxicol Sci. 2004. PMID: 15201435
-
Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.Toxicol Sci. 2006 Apr;90(2):331-6. doi: 10.1093/toxsci/kfj116. Epub 2006 Jan 24. Toxicol Sci. 2006. PMID: 16434500
-
Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-kappaB.Toxicol Appl Pharmacol. 2008 Feb 1;226(3):338-44. doi: 10.1016/j.taap.2007.09.019. Epub 2007 Sep 26. Toxicol Appl Pharmacol. 2008. PMID: 17963809 Free PMC article.
-
Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls.Crit Rev Toxicol. 2006 Oct;36(9):663-94. doi: 10.1080/10408440600845304. Crit Rev Toxicol. 2006. PMID: 17050081 Review.
-
Polychlorinated biphenyls (PCBs): mutagenicity and carcinogenicity.Mutat Res. 1989 Jan;220(1):31-47. doi: 10.1016/0165-1110(89)90007-9. Mutat Res. 1989. PMID: 2492077 Review.
Cited by
-
Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77).Food Chem Toxicol. 2008 Nov;46(11):3467-74. doi: 10.1016/j.fct.2008.08.023. Epub 2008 Aug 30. Food Chem Toxicol. 2008. PMID: 18796325 Free PMC article.
-
The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.Curr Cancer Drug Targets. 2009 Jun;9(4):566-71. doi: 10.2174/156800909788486759. Curr Cancer Drug Targets. 2009. PMID: 19519322 Free PMC article. Review.
-
PCB-153 exposure coordinates cell cycle progression and cellular metabolism in human mammary epithelial cells.Toxicol Lett. 2010 Jul 1;196(2):110-6. doi: 10.1016/j.toxlet.2010.04.005. Epub 2010 Apr 13. Toxicol Lett. 2010. PMID: 20394812 Free PMC article.
-
Ceramide/protein phosphatase 2A axis is engaged in gap junction impairment elicited by PCB153 in liver stem-like progenitor cells.Mol Cell Biochem. 2021 Aug;476(8):3111-3126. doi: 10.1007/s11010-021-04135-z. Epub 2021 Apr 10. Mol Cell Biochem. 2021. PMID: 33837873 Free PMC article.
-
Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.Int J Genomics. 2014;2014:612972. doi: 10.1155/2014/612972. Epub 2014 May 7. Int J Genomics. 2014. PMID: 24895544 Free PMC article. Review.
References
-
- Beg AA, Baltimore D. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death. Science. 1996;274:782–784. - PubMed
-
- Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995;376:167–170. - PubMed
-
- Brown AM, Linhoff MW, Stein B, Wright KL, Baldwin AS, Jr, Basta PV, Ting JP. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol. Cell. Biol. 1994;14:2926–2935. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials